medisourceasia.com

Industry News


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

DCGI to establish multi-level complaint redressal system to address industry grievances

The Drug Controller General of India (DCGI) will soon put in place a multi-level complaint redress mechanism including a grievances box to be manned and opened personally, in a bid to mitigate the irritants of the industry players to the best possible extent.

As part of streamlining the functions vis-à-vis addressing the grievances of the industry, a senior official will be designated to handle the queries and problems every day for a greater time and if needed a whole day in a week. Time-frames for clearing of each application will be fixed and displayed so that applicants can seek justification for delays. ``If still there is any complaint about the delay in clearance or anything else, and was not addressed at different levels, anyone can drop the complaint in the grievances box which will be placed soon in the FDA Bhavan. I will personally open and address the problem listed in it,'' DCGI Dr Surinder Singh informed a gathering of manufacturers recently.

He also assured the industry that they would be consulted through regular workshops before making any major decision on key areas like clinical trials and would meet the representatives of the companies once a month to personally to take the feedbacks.

Faced with shortage of manpower, the immediate effort was to fill up the vacant posts in the CDSCO. Already nine persons have been promoted as assistant drug controllers and advertisement was given to select four deputy drug controllers. Besides, 31 technical assistants are being appointed soon, he disclosed.

Looking forward to a smooth system on par with world-class standards once the E-governance is being fully implemented, the DCGI said the drug inspectors in the North Zone were already given laptops to send reports immediately from the field itself. It would now be extend to the West Zone also, he added.

(Ref: Chronicle Pharmabiz dated 07 July 2008)

GE Sensing develops Labwatch monitoring system for pharma-biotech sector

GE Sensing & Inspection Technologies has developed the Labwatch monitoring system with real time temperature, pressure and humidity data controls. The system equipped with RF ValProbe offers significant economies of scale as it does not require wiring.

The changeover downtime is eliminated, as the hardware can be quickly converted from monitoring into temperature mapping. The system finds extensive application for monitoring installations in stability rooms, freezers, refrigerators, incubators, cold rooms, water baths, clean rooms, laboratories and warehouses of the pharmaceutical and biotech industries.

Labwatch is widely acknowledged as a labour-saving system for monitoring, alarming and reporting on environmental status in the pharma and biotech sectors. It provides the information needed for internal analysis and for documentation to comply with regulatory requirements, specifically with those of FDA regulation 21 CFR Part 11. It also maintains a secure archive of monitored values from all sensors and creates an audit trial of alarms and actions taken by the system and system operators. Typical monitored parameters include: pressure, temperature, humidity, light, both visible and UV, airflow, CO2 and the open/shut status of doors.

The incorporation of the RF ValProbe into the Labwatch system now allows users greater flexibility, significant time saving and reduced risk of data analysis errors.

RF ValProbe system consists of RF wireless loggers, a base station and appropriate software. The loggers provide high accuracy measurement of temperature, pressure and humidity. Data is collected from many loggers over a wide area. Mesh networking technology ensures that no data is lost, by permitting loggers to route data to another logger for subsequent forwarding if the direct path to the base station is blocked. It is the integration of exceptionally reliable and robust RF Mesh technology with the advanced measuring capabilities. The software and data reporting features that accompany the RF technology provide regulatory-compliant text and graph reports. It eliminates the need to download data to an Excel spreadsheet. Encryption guarantees data protection.

(Ref: Chronicle Pharmabiz dated 05 July 2008)


Next
 

Other News

Gujarat To Bolster Healthcare Sector
CII To Organize Seminars On Regulation On Medical Devices
Conference Theme For Next Delhi IPC: “Regulation For Better Healthcare”
B Braun Launches Coroflex Please Drug Eluting Stent In India
HLL, IL&FS Ink Mou For An Integrated Medical Devices And Diagnostic Manufacturing Park
Govt. To Finance Center Of Excellence For Medical Textiles
Kehlescope, A Tongue Depressor For Examining The Oral Cavity, Invented By Indian Doctors
Productivity Council finds 40% SSI units shut due to enforcement of GMP norms
US FDA to establish offices in Delhi, Mumbai, Hyderabad soon
Spurious drugs bill to be moved in next session of parliament
Dr Batra's launches first tele-homeopathic clinic at Mumbai
Centre allots Rs 630 cr for medicinal plants cultivation covering one lakh hectares
DCGI warns illegal units making medical devices, directs to obtain licenses
CCE Software develops two new solutions for Pharma ERP and Medical Rep Management
Welch Allyn launches FlexiPort blood pressure cuffs
US FDA revises communication regulation to drug companies on applications

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next